Open for bids Tender Germany ICB TOT Ref. 152326550

Conclusion not Excluding Drug Discount Agreement. Tender - 152326550

Tender notice from Germany, published on 11 Nov 2026.

Executive Summary

Title/Summary: Tender for non-exclusive discount agreements for the drug Aflibercept in Germany, issued by AOK PLUS - The Health Insurance Fund for Saxony and Thuringia. The contract will be established under an Open-House model, allowing participation until December 31, 2027.

Scope Of Work: This tender involves the establishment of non-exclusive discount agreements for Aflibercept injectable solution, as per § 130a Abs. 8 SGB V. The agreements will be available to all interested pharmaceutical companies that meet participation requirements. The quantities required are unknown and will depend on demand and other factors, with no minimum purchase guarantees. Interested firms must apply for access to the project room on the German Procurement Portal (DTVP) to obtain participation documents, which are subject to confidentiality. The submission of participation requests begins on December 2, 2026, and the agreements will end by December 31, 2027.

Qualification Criterion: Bidder eligibility includes compliance with the participation requirements set out in the project documents available on the DTVP. Interested pharmaceutical companies must apply for access to the project room and adhere to confidentiality regarding the contents of the participation documents. Specific mandatory submissions and technical requirements are detailed in the documents provided in the project room. Late submissions will be considered in the next submission period, and all documents must be securely destroyed if participation is not pursued.

Key facts

Summary
Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Aflibercept Dfl (Atc Code According to Who: S01la05; Except 114.3 Mg/Ml)
TOT Ref. No.
152326550
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
11 Nov 2026
Bid deadline
31 Dec 2027
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Aflibercept Dfl (Atc Code According to Who: S01la05; Except 114.3 Mg/Ml) is 31 Dec 2027. Submit before this date to be considered.

This tender has been issued by AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152326550. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.